Improving heart health through AI text messaging
Using Artificially Intelligent Text Messaging Technology to Improve American Heart Association's Life's Essential 8 Health Behaviors: LE8 Bot + Backup
NA · University of Colorado, Denver · NCT06324981
This study is testing whether different types of text messages, including ones from an AI chatbot and support from a pharmacist, can help people at higher risk for heart disease improve their heart health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 2100 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | University of Colorado, Denver (other) |
| Locations | 3 sites (Denver, Colorado and 2 other locations) |
| Trial ID | NCT06324981 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of three different strategies—generic text messages, interactive AI chatbot messages, and chatbot messages with proactive pharmacist support—in reducing cardiovascular disease risk factors among patients facing health disparities. The study focuses on the American Heart Association's Life's Essential 8 factors, which include blood glucose, cholesterol, blood pressure, physical activity, body mass index, diet, and smoking. By engaging patients in self-management through technology, the trial seeks to improve health outcomes for those disproportionately affected by cardiovascular diseases.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with hypertension, diabetes, or hyperlipidemia who exhibit poor adherence to their prescribed medication.
Not a fit: Patients who do not own a cellphone or are enrolled in hospice or palliative care may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance self-management of cardiovascular risk factors in underserved populations.
How similar studies have performed: Previous studies have shown that text messaging can positively impact self-management behaviors, suggesting potential success for this innovative approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of one or more of the following CV risk factors (i.e., hypertension, diabetes or hyperlipidemia); and * the risk factor is at poor or intermediate health levels as defined by LE8 (e.g., BP\>140/90 mm Hg); and * the patient exhibits poor adherence to prescribed medication to treat the CV risk factor as defined by a delay in refilling the medication within the past 6 months. Exclusion Criteria: * patients who do not have cellphone; or * enrolled in hospice or palliative care; or * Non-English or Spanish speaking; or * enrolled in another clinical trial if denoted in the EHR.
Where this trial is running
Denver, Colorado and 2 other locations
- Denver Health — Denver, Colorado, United States (RECRUITING)
- Salud Family Health Centers — Fort Lupton, Colorado, United States (NOT_YET_RECRUITING)
- STRIDE Community Health Centers — Wheat Ridge, Colorado, United States (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: P. Michael Ho, MD PhD — University of Colorado, Denver
- Study coordinator: Lisa Sandy, MA
- Email: lisa.sandy@cuanschutz.edu
- Phone: 570-594-1564
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiovascular Diseases, Lifestyle Factors, cardiovascular disease, Life's Essential 8, mHealth